Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects Previously Immunised With an Investigational Dengue or Yellow Fever Vaccine

NCT00730288 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00730288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects Previously Immunised With an Investigational Dengue or Yellow Fever Vaccine
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
January 31, 2008
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue, dengue fever, dengue hemorrhagic fever, dengue virus